Hyperkalemia

Dyskalemia at ICU Admission Ups Cardiac Event, Death Risks

Publish Date January 15, 2020

Failure to correct dyskalemia within 2 days increased 28-day mortality risk.

Rapid Hyperkalemia Correction in the Emergency Department May Cut Death Risk

Publish Date January 6, 2020

In a study, emergency department patients who experienced serum potassium normalization within 3 to 8 hours had half the death risk of those with persistent hyperkalemia.

Patiromer Effective Up to 1 Year in Advanced Diabetic Kidney Disease

Publish Date December 17, 2019

In a 52-week study, daily treatment with patiromer maintained normokalemia in patients, regardless of age.

Reducing RAASi Dose Found to Raise MACE, Death Risk in CKD, Heart Failure

Publish Date December 10, 2019

In a study, CKD patients receiving less than half of a guideline-recommended dose of RAASi had a nearly 6-fold higher risk for death and 2-fold higher risk for MACE than patients receiving 50% or more of the recommended dose.

Adding Aliskiren to Losartan Ups Hyperkalemia Risk in CKD

Publish Date December 5, 2019

Adding aliskiren to losartan in patients with nondiabetic chronic kidney disease does not result in a greater renal protection and increases their risk of hyperkalemia, a study found.

Monthly Blood Testing in the Hemodialysis Population Questioned

Publish Date December 4, 2019

In a study, monthly blood testing vs testing every 6 weeks was not associated with a lower risk of death among prevalent and incident hemodialysis (HD) patients, but is associated with an increased risk of hyperkalemia, cardiovascular events, and all-cause hospitalization among incident HD patients.

Hyperkalemia Drug Safe for Use in Adolescent CKD Patients

Publish Date November 14, 2019

Preliminary data show that treatment with patiromer is well tolerated and results in clinically meaningful decreases in serum potassium.

Hyperkalemia Excursions May Better Predict Death Risk in Hemodialysis

Publish Date November 12, 2019

In a study of hemodialysis patients, the more hyperkalemia excursions, the higher the risk for short-term mortality.

Hyperkalemia Impairs Quality of Life in CKD, Dialysis

Publish Date November 11, 2019

KDQOL and EuroQol-5D-3L responses show worse quality of life among kidney disease patients who develop hyperkalemia.

Hyperkalemia Progression Rates Described

Publish Date November 9, 2019

In a study, nearly 17% of patients with mild hyperkalemia progressed to moderate to severe hyperkalemia during the 2 years following the date of their first mild hyperkalemia event.